At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- Call to extend duty cuts on critical inputs soon June 13, 2026 4:34 am ETAuto While the Centre is likely to extend duty relief on petrochemicals till September, other industries seeking relief include ceramics and diamond polishing, polyester textiles, specialty chemicals, flexible packaging, and auto components, according to the …
- CDA data reveals trends on drug approvals and reimbursements in Canada June 12, 2026 6:49 pm Pharmaceutical Technology In April 2026, Canada’s Drug Agency (CDA) released an expanded data set offering insights and trends within its regulatory system for drug approvals and reimbursement in Canada. This is an expansion from CDA’s original set of data, which was published in …
- Scientific Conclave on Indian Pharmacopoeia held in Haridwar; aims to enhance awareness June 12, 2026 1:17 pm ETManufacturing.in The sessions provided participants with practical insights into the application of IP standards in pharmaceutical manufacturing and quality control. The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and …
- Novo Nordisk comeback stirs as Wegovy pill wins UK approval June 12, 2026 12:11 pm Pharmaceutical Technology The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another regulatory win for the drugmaker as it looks to close the gap to obesity market rival Eli Lilly. The agency has …
- How Enterprises Are Making AI Work At Scale June 11, 2026 7:59 pm ETBFSI.com Artificial intelligence is entering a decisive phase where enterprise adoption is scaling rapidly, even as organizations work through questions of value, governance and long-term impact. According to Gartner, more than 80 percent of enterprises are …
- Novartis $12bn bet on Avidity well placed after mid-stage FSHD win June 11, 2026 4:30 pm Clinical Trials Arena Novartis’ $12bn Avidity Biosciences buyout is looking increasingly well positioned, as one of the latter company’s lead assets, delpacibart braxlosiran (del-brax), has posted a mid-stage win in the rare muscle wasting disease facioscapulohumeral muscular …
- The talent crisis in pharma manufacturing: Why building future leaders is critical to fighting AMR June 11, 2026 4:24 pm ETManufacturing.in The workforce challenge is increasingly emerging as a structural risk to global health preparedness in the field of AMR.The conversation on antimicrobial resistance (AMR) is mostly about molecules. It should also be about people. It is estimated that drug- …
- Drug developers eye sport’s biggest stage as World Cup fever builds June 11, 2026 3:48 pm Pharmaceutical Technology As Mexico prepares to take on South Africa in the opening game of the 2026 FIFA World Cup today (11 June), a handful of pharmaceutical companies are set to contribute off the pitch in what could be the biggest sporting event in history. This year’s …
- SCW.AI Assembles Industry Advisory Board to Accelerate Modernization of Pharma Manufacturing June 11, 2026 1:00 pm EIN Presswire SCW.AI assembles a group of leaders to guide its mission to modernize pharmaceutical manufacturing and help organizations meet the evolving demands of AI. ATLANTA, GA, UNITED STATES, June 11, 2026 /EINPresswire.com/ -- SCW.AI, a leading provider …
- IPC holds Scientific Conclave on Indian Pharmacopoeia 2026 in Haridwar June 11, 2026 12:56 pm DD News The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health and Family Welfare, organised a Scientific Conclave and Interactive Session on Indian Pharmacopoeia (IP) 2026 in Haridwar to promote awareness of pharmacopoeial standards and …
- SA’s Tiger Wheel & Tyre sold to Japanese investment giant Marubeni June 11, 2026 12:41 pm Moneyweb South Africa’s pre-eminent household automotive brands, Tiger Wheel & Tyre and Tyres & More, are officially moving into Japanese ownership. In a major cross-border transaction announced on 10 June 2026, Tokyo-listed global trading and investment …
- Nifty, Sensex Recover, Falter Again; Broader Market Selloff Continues – Thursday Market Report June 11, 2026 12:16 pm Moneylife India On Thursday, 1,384 stocks advanced, 2,807 declined, and 21.4 remained unchanged on the Bombay Stock Exchange with an advance-decline ratio of 0.49, indicating a positive closing. The trend of the major indices on Thursday’s trading is given in the table …
- Biobetters Market to Value USD 131.19 Billion by 2035, Expanding at an 8.39% CAGR as Next-Generation Biologics Gain Momentum – SNS Insider June 11, 2026 12:07 pm Business Upturn U.S. Biobetters Market to Hit USD 54.94 Billion and Europe Market to Reach USD 37.29 Billion by 2035, Driven by Biologics Patent Expirations and Therapeutic Innovation. Austin, United States, June 11, 2026 (GLOBE NEWSWIRE) — “According to SNS Insider, the …
- Govt holds scientific conclave to boost pharma quality compliance June 11, 2026 11:52 am The Hans India New Delhi: A scientific conclave and interactive session on the Indian Pharmacopoeia (IP) 2026 was held in Haridwar to raise awareness of new provisions under IP and promote quality compliance across the pharmaceutical manufacturing sector, the government …
- Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) June 11, 2026 10:30 am EIN Presswire Austin, TX, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Next Generation Sequencing Services Market Size, Trends and Insights By Service Type (Human Genome Sequencing Services, Microbial Genome- …
- Molecular Cytogenetics Market to reach USD 8.52 Billion by 2035 at 10.15% CAGR June 11, 2026 9:54 am EIN Presswire Molecular Cytogenetics Market to Surge from USD 3.72 Billion in 2026 to USD 8.52 Billion by 2035-Powered by FDA Accelerated FISH Panel Clearance, NY, CA, UNITED STATES, June 11, 2026 /EINPresswire.com/ -- As per Market Research Future, the …
- Dogsee Chew plans to raise Rs 300 crore to fund new factory, product launches and its next growth phase June 11, 2026 9:31 am ETRetail.com Dogsee Chew is gearing up for its next phase of global expansion with a planned Rs 300 crore fundraise, as the pet wellness brand looks to scale manufacturing, launch new products, and strengthen its presence in key international markets, Sneh Sharma, co- …
- Can Medicines Made In Space Transform Healthcare On Earth? Inside Pharma’s Race To Low Earth Orbit June 11, 2026 1:54 am Inventiva For much of the modern space age, commercial opportunities in orbit were largely confined to satellite communications, navigation systems, Earth observation, and defence-related applications. However, a combination of falling launch costs, reusable rockets …
- What Nippon India Small Cap Fund bought and sold in May 2026 — top 10 holdings revealed June 10, 2026 6:49 pm Mint Nippon India Small Cap Fund is the largest open-ended small-cap mutual fund in India with an AUM of ₹72,673 crores. As per SEBI regulations, small-cap funds must invest at least 65% of their assets in small-cap stocks. Hence, tracking the portfolio changes …
- Hetero partners with Richter to develop, market Semaglutide injection globally June 10, 2026 6:32 pm ETManufacturing.in Hetero has already invested in technology setup and registration batch manufacturing, with regulatory filings underway, and EU and US submissions planned for 2027. Hyderabad-based pharma major Hetero Labs has signed a global collaboration agreement with …
- Sensex today | Stock Market Highlights: Sensex, Nifty end flat as early gains fade; gold prices slide sharply June 10, 2026 12:26 pm The Hindu Business Line A blue-toned stock image showing coin stacks, a bar-style chart, and a rising line to convey financial growth, market trends, and investment analysis in a professional business context. istockphoto for BL Sensex Today, Nifty 50 | Stock Market Live Updates …
- Salicylic Acid Market Driven by Growing Demand from Pharmaceuticals, Personal Care, and Food Preservation Industries June 10, 2026 12:16 pm EIN Presswire Asia-Pacific held the largest share of the global salicylic acid market in 2020, contributing more than one-third of total revenue. WILMINGTON, DE, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- The global salicylic acid market is witnessing …
- Centre may extend relief measures for pharma sector amid West Asia crisis: MOCI official June 10, 2026 12:08 pm ETGovernment The Indian government is closely watching the West Asia crisis. Relief measures for the pharma sector, including duty exemptions on key inputs, might be extended beyond June 30, 2026. Hyderabad: The Centre is closely monitoring the evolving West Asia …
- Ayurveda Market to reach USD 107.62 Billion by 2035 at 17.82% CAGR June 10, 2026 11:09 am EIN Presswire Ayurveda Market to Surge from USD 24.55 Billion in 2026 to USD 107.62 Billion by 2035- Powered by Plant-Based Wellness, AYUSH Infrastructure NY, CA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- As per Market Research Future, the global …
- Drug Repurposing Market to reach USD 52.80 Billion by 2035 at 3.1% CAGR June 10, 2026 11:08 am EIN Presswire Drug Repurposing Market to Surge from USD 40.40 Bn in 2026 to USD 52.80 Bn by 2035-Powered by Patent-Cliff Revenue Pressure, AI-Driven Drug Repositioning NY, CA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- As per Market Research Future …